Publication
Boosting healthcare capacity with AI
Hear from IQVIA experts Aurelio Arias and Sarah Rickwood on how AI in healthcare could bridge a significant capacity gap.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
Video Player is loading.
AI designed for healthcare & life sciences
Everything we do in our industry ultimately has an impact on patients, so it’s imperative that we deliver AI that’s built on a foundation of unparalleled data, expertise, and trust.
With IQVIA Healthcare-grade AI®, we’re building on our rich history of deploying AI to connect the right data, technology, and expertise to address the unique needs of each challenge we help our customers solve.
With IQVIA Healthcare-grade AI®, we’re building on our rich history of deploying AI to connect the right data, technology, and expertise to address the unique needs of each challenge we help our customers solve.
IQVIA Healthcare-grade AI®
IQVIA partnering with NVIDIA to accelerate Healthcare-grade AI®
This collaboration will create new ways for customers to accelerate their efforts to improve patient outcomes.
IQVIA AI is trained on high-quality data and deep domain expertise. This allows us to connect disparate pieces of healthcare data, from multiple sources, and generate reliable insights that can increase efficiency and accelerate innovation. This enables our customers to lead the industry in exciting ways—from identifying patients at the earliest stage of disease, to developing new and more effective treatments, to helping people live longer, healthier lives.
Advances in science, technology, and healthcare are converging to enable never-before-seen innovations that have the potential to revolutionize patient outcomes. At IQVIA, we are making this potential a reality, and are committed to going beyond the hype to ensure we’re taking a responsible approach, backed by scientific rigor, to get results that change people’s lives for the better.
Generative AI
Meet your new AI Assistant
IQVIA AI Assistant is a powerful generative AI tool that lets you interact with our solutions and products like never before. Ask questions, analyze data, and get insights you can trust in moments instead of hours or days.
With an extensive history of applying AI to solutions for life sciences and healthcare, we continue to build on our expertise by leveraging new technologies to ensure we’re getting the best results for you, and ultimately for patients.
Our latest thinking on generative AI
CASE STUDIES
Improving patient outcomes and closing care gaps
IQVIA is working with life sciences companies, governments, and non-profit organizations to power smarter healthcare with advanced AI capabilities.
Closing care gaps with Social Determinants of Health (SDoH)
Challenge: Social factors such as employment status, financial situation, or stress are useful predictors of health outcomes but are often only captured in unstructured physician notes. For example, NorthShore University HealthSystem found only 0.1% of patient records had these fields completed.
Solution: IQVIA assisted NorthShore with the use of Natural Language Processing (NLP) to assess that unstructured data across multiple sources.
Results: NorthShore is now able to help close care gaps by identifying and screening 56% more at-risk patients. In one example, they were able to identify at least one SDoH risk factor in 30% of their patient population (up from only 0.1%).
Solution: IQVIA assisted NorthShore with the use of Natural Language Processing (NLP) to assess that unstructured data across multiple sources.
Results: NorthShore is now able to help close care gaps by identifying and screening 56% more at-risk patients. In one example, they were able to identify at least one SDoH risk factor in 30% of their patient population (up from only 0.1%).
Reducing risk of stroke for AFib patients
Challenge: Atrial Fibrillation (AFib) patients are 5x more likely to have a stroke. IQVIA partnered with the UK National Health Service to reduce AFib related strokes through identifying at-risk patients.
Solution: The risk of stroke for AFib patients was predicted using EMR data including age, gender, and clinical risk factors (e.g. Congestive Heart Failure, Hypertension, Stroke/Transient Ischemic Attack, Diabetes, Vascular Disease).
Results: Annul strokes reduced by approximately 22% during the implementation phase compared to the prior period. This also led to an estimated reduction in healthcare costs amounting to an annual savings of approximately $2m.
Solution: The risk of stroke for AFib patients was predicted using EMR data including age, gender, and clinical risk factors (e.g. Congestive Heart Failure, Hypertension, Stroke/Transient Ischemic Attack, Diabetes, Vascular Disease).
Results: Annul strokes reduced by approximately 22% during the implementation phase compared to the prior period. This also led to an estimated reduction in healthcare costs amounting to an annual savings of approximately $2m.
Improving care for patients with Type 1 Diabetes
Challenge: Nearly 40% of adults with Type 1 Diabetes are initially misdiagnosed with Type 2. IQVIA worked with the Juvenile Diabetes Research Foundation (JDRF) to identify Type 1 patients most likely to be misdiagnosed.
Solution: IQVIA developed an AI algorithm on EMR data, to identify misdiagnosed Type 1 among patients with Type 2 at different points in the patient’s treatment journey.
Results: Inputs into the AI algorithm are routinely collected in EMR data – thus available within any Healthcare Organization (HCO) providing opportunity to deploy the program at scale. The algorithm is currently being prospectively validated at 4 US HCOs testing 2 different scaling paths.
Solution: IQVIA developed an AI algorithm on EMR data, to identify misdiagnosed Type 1 among patients with Type 2 at different points in the patient’s treatment journey.
Results: Inputs into the AI algorithm are routinely collected in EMR data – thus available within any Healthcare Organization (HCO) providing opportunity to deploy the program at scale. The algorithm is currently being prospectively validated at 4 US HCOs testing 2 different scaling paths.
Enhancing routine care for diabetes and CVD
Challenge: The government of one Middle East country is investing in AI to make better healthcare decisions in the diagnosis and treatment of both diabetes and cardiovascular disease.
Solution: IQVIA developed 14 decision support tools that can be used by physicians to help guide screening, improve preventative care and optimise disease management.
Results: The program is being delivered by a cross-functional team of local and global IQVIA experts over a three year period.
Solution: IQVIA developed 14 decision support tools that can be used by physicians to help guide screening, improve preventative care and optimise disease management.
Results: The program is being delivered by a cross-functional team of local and global IQVIA experts over a three year period.
Identifying patients at risk for respiratory disease
Challenge: A client launched a new product to treat respiratory disease. They needed help identifying patient cohorts with this specific unmet need to then reach physicians most likely to have these patients.
Solution: IQVIA deployed the AI/ML Platform capability to identify and profile eligible patient populations with unmet needs. The patients were profiled based on sub-national concentration, demographics and other clinical drivers, with focus on physicians treating them.
Results: Patients predicted for high likelihood to have respiratory disease with 86% precision, while removing approximately 30% of non-target patients from the target population data. Furthermore, a 6-month analysis of patients on this new treatment showed a 17% reduction in uncontrolled disease status.
Solution: IQVIA deployed the AI/ML Platform capability to identify and profile eligible patient populations with unmet needs. The patients were profiled based on sub-national concentration, demographics and other clinical drivers, with focus on physicians treating them.
Results: Patients predicted for high likelihood to have respiratory disease with 86% precision, while removing approximately 30% of non-target patients from the target population data. Furthermore, a 6-month analysis of patients on this new treatment showed a 17% reduction in uncontrolled disease status.
Responsible AI
We work with partners globally to responsibly advance AI
Pragmatic Application of Healthcare AI Governance
This document explores regulatory frameworks and guidelines for Artificial Intelligence (AI), highlights common foundational principles of best practice, and provides tangible examples of data and analytics management approaches to meet some of these best practice guidelines.
ChatGPT, Large Language Models and NLP – a clinical perspective
This is part one of a two-part series exploring the potential opportunities and risks of using ChatGPT and large language models in healthcare, this blog will focus on the clinical perspective while the second blog will look closer at the technology and considerations for using in a healthcare setting.
Related solutions
Health Data Apps & AI
See how we bring together global data assets, AI-powered analytic solutions, and industry-leading healthcare expertise
NLP Data Factory
Mobilize your textual data with enterprise NLP extraction at scale
IQVIA NLP Platform
Insights are trapped in mountains of text. NLP sets them free.
Explore More
IQVIA and HEALTHCARE-GRADE AI are trademarks of IQVIA Inc.